Medication info
Robo One Tablet 10 Milligrams (Rosuvastatin Calcium)

Robo One Tablet 10 Milligrams (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Wonkwang Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
PTP packaging - 28 tablets/PTP [(14 tablets/PTP × 2)]
Approval status
Active

MFDS item code 202000554 · Approved 2020.02.03 · Insurance code 662600860

Summary

Main use
Treatment of hyperlipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, up to a maximum of 20 mg daily. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity : Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Wonkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hyperlipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • dyslipidemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used as an adjunct to dietary changes for patients with primary hypercholesterolemia or mixed dyslipidemia that cannot be controlled with diet and exercise alone. It can also be used in conjunction with dietary changes or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia to enhance efficacy. It is utilized to lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. Especially, it is also used as an adjunct to dietary changes in pediatric patients with heterozygous familial hypercholesterolemia aged between 10 and 17 years who meet certain criteria. It is also beneficial for patients with primary dysbetalipoproteinemia. Finally, in men over 50 years and women over 60 years with elevated high-sensitivity C-reactive protein levels and additional risk factors for cardiovascular disease, it contributes to reducing the risk of stroke, myocardial infarction, and revascularization procedures, thereby lowering cardiovascular disease risk. This medication effectively improves cholesterol and cardiovascular risk factors.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, up to a maximum of 20 mg daily. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity : Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be administered to specific patients. For example, patients allergic to any component of this medication, those with severely impaired liver function, patients with muscle disorders, and certain patients with decreased renal function should not use this medication. Furthermore, pregnant or breastfeeding women, and women of childbearing potential should refrain from taking this medication unless appropriate contraception is used. This medication may affect liver function, so individuals with a history of liver disease or those consuming alcohol heavily should undergo liver function tests before taking the medication and should continue regular testing during treatment. If symptoms such as muscle pain or weakness occur, medical attention should be sought immediately, and in severe cases, discontinuation of the medication may be necessary. The use of this medication in conjunction with certain drugs may elevate blood concentrations, increasing the risk of muscle-related side effects, so it is crucial to consult with a healthcare professional before taking any other medications. If pregnant or breastfeeding, this medication may pose risks to the fetus or infant, so it should not be used, and women of childbearing potential should use appropriate contraception before use. In case of overdose, there is no specific antidote, and treatment should be based on symptoms, along with liver function and muscle enzyme testing. This medication may cause side effects such as dizziness or headaches, so caution is necessary when driving or operating machinery. Finally, this medication may rarely cause severe skin reactions, liver damage, or kidney problems in some individuals, so if new symptoms arise, immediate consultation with a healthcare provider is advised.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a sealed container. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help preserve the medication's effectiveness over time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

PTP packaging - 28 tablets/PTP [(14 tablets/PTP × 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.